Production (Stage)
NanoSphere Health Sciences Inc.
NSHS
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 47.17% | -0.23% | -1.55% | -25.83% | -44.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.29% | -22.28% | -10.12% | -16.64% | -45.21% |
| Operating Income | -39.29% | 22.28% | 10.12% | 16.64% | 45.21% |
| Income Before Tax | -135.35% | 842.08% | -0.48% | 21.87% | 22.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -135.35% | 842.08% | -0.48% | 21.87% | 22.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -135.35% | 842.08% | -0.48% | 21.87% | 22.95% |
| EBIT | -39.29% | 22.28% | 10.12% | 16.64% | 45.21% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -137.50% | 849.06% | -2.50% | 22.37% | 23.08% |
| Normalized Basic EPS | -136.00% | -75.76% | 0.00% | 22.92% | 24.24% |
| EPS Diluted | -137.50% | 849.06% | -2.50% | 22.37% | 23.08% |
| Normalized Diluted EPS | -136.00% | -75.76% | 0.00% | 22.92% | 24.24% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |